Health committee  Thank you very much. I am proud to represent the companies who conduct research and make discoveries in order to save lives and improve our health system. We are very proud that we are in the business of improving and saving lives. Our organization invests over a billion dollar

Health committee  We are quite eager to work.... We want to work hand in hand with governments. As for catastrophic coverage, we find it unacceptable that access to medications is not the same from one region to another in this country. We are ready to establish a partnership with provincial gove

Health committee  We had no consultations on these amendments.

Health committee  That's what I just said.

Health committee  May I respond?

Health committee  The statements the generics have made are unfounded.

Health committee  If I have time.

Health committee  Thank you very much, Madam Chair.

Health committee  Clearly, we believe in innovation and improving lives, and I think my figures clearly state that we actually are the ones saving lives. Generics are trying to copy our research, benefit from the fruits of our research. The statements by the generics are completely unfounded. Thi

Health committee  Well, if you want to go back and forth, but—

Health committee  Well, very clearly—and I actually do want to debate health care and do believe that—

Health committee  I'm an ex-parliamentarian too, so I—

Health committee  I very much believe that if we protect IP and at the same time ensure that we have proper pricing in this country and ensure good access to innovative medicines, we can in fact be an effective interlocutor, if I could say so, on the 10-year plan. I believe that access to innovati

Health committee  Madam Chair, actually, I would like to respond--really quite quickly--that we have been constantly in conversation with the industry department. We are constantly.... I wanted to clarify that.

Industry committee  Thank you, honourable members. We are very pleased to join you today. I hope that we can contribute to the discussion and that the debate generated will be conducive to progress and innovation in access to medicines for developing countries. I agree with the opinions shared toda